Protein Kinase G Phosphorylates Soluble Guanylyl Cyclase on Serine 64 and Inhibits Its Activity

Zongmin Zhou; Nazish Sayed; Anastasia Pyriochou; Charis Roussos; David Fulton; Annie Beuve; Andreas Papapetropoulos

doi:10.1161/ATVBAHA.108.165043

Back

Protein Kinase G Phosphorylates Soluble Guanylyl Cyclase on Serine 64 and Inhibits Its Activity

Journal article

Open access

Peer reviewed

Protein Kinase G Phosphorylates Soluble Guanylyl Cyclase on Serine 64 and Inhibits Its Activity

Zongmin Zhou, Nazish Sayed, Anastasia Pyriochou, Charis Roussos, David Fulton, Annie Beuve and Andreas Papapetropoulos

Arteriosclerosis, thrombosis, and vascular biology, Vol.28(10), pp.1803-1810

10/2008

DOI: https://doi.org/10.1161/ATVBAHA.108.165043

PMCID: PMC2763424

PMID: 18635821

Abstract

Objective— Binding of nitric oxide (NO) to soluble guanylyl cyclase (sGC) leads to increased cGMP synthesis that activates cGMP-dependent protein kinase (PKG). Herein, we tested whether sGC activity is regulated by PKG. Methods and Results— Overexpression of a constitutively active form of PKG (ΔPKG) stimulated 32 P incorporation into the α1 subunit. Serine to alanine mutation of putative sites revealed that Ser64 is the main phosphorylation site for PKG. Using a phospho-specific antibody we observed that endogenous sGC phosphorylation on Ser 64 increases in cells and tissues exposed to NO, in a PKG-inhibitable manner. Wild-type (wt) sGC coexpressed with ΔPKG exhibited lower basal and NO-stimulated cGMP accumulation, whereas the S64A α1/β1 sGC was resistant to the PKG-induced reduction in activity. Using purified sGC we observed that the S64D α1 phosphomimetic /β1 dimer exhibited lower Vmax; moreover, the decrease in Km after NO stimulation was less pronounced in S64D α1/β1 compared to wild-type sGC. Expression of a phosphorylation-deficient sGC showed enhanced responsiveness to endothelium-derived NO, reduced desensitization to acute NO exposure, and allowed for greater VASP phosphorylation. Conclusions— We conclude that PKG phosphorylates sGC on Ser64 of the α1 subunit and that phosphorylation inhibits sGC activity, establishing a negative feedback loop.

Files and links (1)

url

https://doi.org/10.1161/ATVBAHA.108.165043View

Version of Record (VoR) Open

Metrics

15 Record Views

31 Times Cited - Web of Science

Details

Title: Protein Kinase G Phosphorylates Soluble Guanylyl Cyclase on Serine 64 and Inhibits Its Activity
Creators: Zongmin Zhou - From the M. Simou Laboratories, Evangelismos Hospital, Critical Care Department (Z.Z., C.R., A.P.), University of Athens School of Medicine, Greece; the Department of Pharmacology (N.S., A.B.), New Jersey Medical School, UDMNJ, Newark; the Laboratory of Molecular Pharmacology, Department of Pharmacy (A.P.), University of Patras, Greece; and the Vascular Biology Center (D.F.), Medical College of Georgia, Augusta
Nazish Sayed - From the M. Simou Laboratories, Evangelismos Hospital, Critical Care Department (Z.Z., C.R., A.P.), University of Athens School of Medicine, Greece; the Department of Pharmacology (N.S., A.B.), New Jersey Medical School, UDMNJ, Newark; the Laboratory of Molecular Pharmacology, Department of Pharmacy (A.P.), University of Patras, Greece; and the Vascular Biology Center (D.F.), Medical College of Georgia, Augusta
Anastasia Pyriochou - From the M. Simou Laboratories, Evangelismos Hospital, Critical Care Department (Z.Z., C.R., A.P.), University of Athens School of Medicine, Greece; the Department of Pharmacology (N.S., A.B.), New Jersey Medical School, UDMNJ, Newark; the Laboratory of Molecular Pharmacology, Department of Pharmacy (A.P.), University of Patras, Greece; and the Vascular Biology Center (D.F.), Medical College of Georgia, Augusta
Charis Roussos - From the M. Simou Laboratories, Evangelismos Hospital, Critical Care Department (Z.Z., C.R., A.P.), University of Athens School of Medicine, Greece; the Department of Pharmacology (N.S., A.B.), New Jersey Medical School, UDMNJ, Newark; the Laboratory of Molecular Pharmacology, Department of Pharmacy (A.P.), University of Patras, Greece; and the Vascular Biology Center (D.F.), Medical College of Georgia, Augusta
David Fulton - From the M. Simou Laboratories, Evangelismos Hospital, Critical Care Department (Z.Z., C.R., A.P.), University of Athens School of Medicine, Greece; the Department of Pharmacology (N.S., A.B.), New Jersey Medical School, UDMNJ, Newark; the Laboratory of Molecular Pharmacology, Department of Pharmacy (A.P.), University of Patras, Greece; and the Vascular Biology Center (D.F.), Medical College of Georgia, Augusta
Annie Beuve - From the M. Simou Laboratories, Evangelismos Hospital, Critical Care Department (Z.Z., C.R., A.P.), University of Athens School of Medicine, Greece; the Department of Pharmacology (N.S., A.B.), New Jersey Medical School, UDMNJ, Newark; the Laboratory of Molecular Pharmacology, Department of Pharmacy (A.P.), University of Patras, Greece; and the Vascular Biology Center (D.F.), Medical College of Georgia, Augusta
Andreas Papapetropoulos - From the M. Simou Laboratories, Evangelismos Hospital, Critical Care Department (Z.Z., C.R., A.P.), University of Athens School of Medicine, Greece; the Department of Pharmacology (N.S., A.B.), New Jersey Medical School, UDMNJ, Newark; the Laboratory of Molecular Pharmacology, Department of Pharmacy (A.P.), University of Patras, Greece; and the Vascular Biology Center (D.F.), Medical College of Georgia, Augusta
Publication Details: Arteriosclerosis, thrombosis, and vascular biology, Vol.28(10), pp.1803-1810
Date published: 10/2008
Academic Unit: Pharmacology (NJMS)
Language: English
Resource Type: Journal article
Identifiers: 991031664289904646